Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Ascorbic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.83 |
| ▸ | LMNA | P02545 | 3/20 | 0.83 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.83 |
| ▸ | RECQL | P46063 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.52 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.52 |
| ▸ | TST | Q16762 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | TYR | P14679 | 2/20 | 0.43 |
| ▸ | MANBA | O00462 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.31 |
| ▸ | ACP1 | P24666 | 1/20 | 0.31 |
| ▸ | CDC25B | P30305 | 1/20 | 0.31 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.31 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.31 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ascorbic Acid SCHEMBL31356983 | 1.00 | MAPT (0.83) | MAPTLMNAL3MBTL1RECQLTDP1 | |
| Ascorbic Acid SCHEMBL28255170 | 1.00 | MAPT (0.83) | MAPTLMNAL3MBTL1RECQLTDP1 | |
| Ascorbic Acid SCHEMBL15226289 | 0.95 | MAPT (0.86) | MAPTLMNAL3MBTL1RECQLTDP1 | |
| Ascorbic Acid SCHEMBL10642367 | 0.93 | MAPT (0.83) | MAPTLMNAL3MBTL1RECQLTDP1 | |
| Ascorbic Acid SCHEMBL29992966 | 0.93 | MAPT (0.89) | MAPTLMNAL3MBTL1RECQLTDP1 | |
| Ascorbic Acid SCHEMBL4146647 | 0.93 | MAPT (0.96) | MAPTLMNAL3MBTL1RECQLTDP1 | |
| Ascorbic Acid SCHEMBL22589022 | 0.93 | MAPT (0.96) | MAPTLMNAL3MBTL1RECQLTDP1 | |
| Ascorbic Acid SCHEMBL5432988 | 0.92 | MAPT (0.86) | MAPTLMNAL3MBTL1RECQLTDP1 | |
| Ascorbic Acid SCHEMBL5879339 | 0.91 | MAPT (0.93) | MAPTLMNAL3MBTL1RECQLTDP1 | |
| Ascorbic Acid SCHEMBL2096728 | 0.91 | MAPT (0.93) | MAPTLMNAL3MBTL1RECQLTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12370130-B1 | Preparation method for powder product, powder product, and powder commodity | A & H INTERNATIONAL COSMETICS CO., LTD (CN) | 2025-07-29 | — | — | US | claimed |
| EP-4534067-A1 | PREPARATION METHOD FOR POWDER PRODUCT, POWDER PRODUCT, AND POWDER COMMODITY | A & H International Cosmetics Co., Ltd (CN) | 2025-04-09 | — | — | EP | claimed |
| CN-116139023-B | Preparation method of powder product, powder product and powder product | 上海臻臣化妆品有限公司 | 2024-10-29 | — | — | CN | claimed |
| WO-2024169192-A1 | PREPARATION METHOD FOR POWDER PRODUCT, POWDER PRODUCT, AND POWDER COMMODITY | 上海臻臣化妆品有限公司 | 2024-08-22 | — | — | WO | claimed |
| WO-2024134665-A1 | A CLEANSING COMPOSITION, AND APPLICATIONS THEREOF | L'OREAL (FR) | 2024-06-27 | — | — | WO | claimed |
| CN-117617416-A | Expanded compound feed for cage barb cyclocheilus grahami cultivation and cultivation method | 通威农业发展有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-117281745-A | Whitening essence emulsion containing III type collagen and preparation method of whitening essence emulsion | 广东菲塔赫医药生物科技有限公司 | 2023-12-26 | — | — | CN | claimed |
| CN-116807951-A | Repairing composition for damaged skin and preparation method thereof | 广东菲塔赫医药生物科技有限公司 | 2023-09-29 | — | — | CN | claimed |
| CN-116139023-A | Preparation method of powder product, powder product and powder product | 上海臻臣化妆品有限公司 | 2023-05-23 | — | — | CN | claimed |
| CN-115517319-B | Preparation method of papaya stem and leaf fermented feed | 广西兴盛生物科技有限公司 | 2023-03-10 | — | — | CN | claimed |
| CN-114711374-A | Composite nutrient powder of ferment fibre and its preparation method | 湖南达侑科技有限公司 | 2022-07-08 | — | — | CN | claimed |
| CN-114128805-A | Premix for improving fat pork quality | 江苏奥迈生物科技有限公司 | 2022-03-04 | — | — | CN | claimed |
| CN-105832667-B | A kind of long chain fat emulsion injection and preparation method thereof containing olive oil | 济南康和医药科技有限公司 | 2018-11-30 | — | — | CN | claimed |
| CN-108289829-A | Surface modification functional composition | 株式会社 LG 生活健康 | 2018-07-17 | — | — | CN | claimed |
| CN-105832667-A | Olive oil containing long-chain fat emulsion injection and preparation method thereof | 济南康和医药科技有限公司 | 2016-08-10 | — | — | CN | claimed |
| CN-105534726-A | Cosmetic | FUJIFILM CORP | 2016-05-04 | — | — | CN | claimed |
| CN-103813776-A | Cosmetic use against infrared radiation | COTY GERMANY GMBH | 2014-05-21 | — | — | CN | claimed |
| CN-1951383-A | Stabilized medical and cosmetic composition containing catechin | AMERICIAN ANAIREN LIFE SCIENCE (US) | 2007-04-25 | — | — | CN | claimed |
| US-5607921-A | Stabilized cosmetic or dermatological composition containing several precursors of the same active agent in order to maximize its release, and use thereof | L'OREAL (FR) | 1997-03-04 | — | — | US | claimed |
| EP-0667145-B1 | Stabilized cosmetic or dermatologic composition containing several precursors of a same active agent | OREAL (FR) | 1996-09-25 | — | — | EP | claimed |